Standardization of Spatial Neglect Assessment Tests
NOTEN
1 other identifier
interventional
210
1 country
1
Brief Summary
Spatial neglect is a common cognitive disorder in stroke patients, characterized by a lateralized deficit in attention and intention. This research focuses on defining norms for tests to assess spatial neglect. The norms correspond to the results obtained in a population free of any disorder that could have an impact on test performance. These results can vary in a normal, non-pathological way, with certain parameters such as age, sex, laterality or level of education. Defining these norms in healthy volunteers is therefore essential for interpreting results in patients suspected of spatial neglect, and in particular for defining pathological thresholds above which the diagnosis of spatial neglect can be retained. To answer the research question, we plan to include 210 people with no central neurological disease (stroke, epilepsy and multiple sclerosis in particular), in a single-center study in the neurovascular department of the Raymond-Poincaré hospital (Garches). The 210 subjects will be divided into 10-year age groups, from 20 to 89 years, with the recruitment of 30 participants per age group (15 men and 15 women): 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, 80-89 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2025
CompletedFirst Posted
Study publicly available on registry
August 28, 2025
CompletedStudy Start
First participant enrolled
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 7, 2027
February 10, 2026
July 1, 2025
1 year
August 20, 2025
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To establish average scores for healthy French-speaking volunteers without central neurological disorders on the Apples Cancellation Test (from the BCoS), using French-translated administration and scoring instructions
The average scores for healthy French-speaking volunteers without central neurological disorders on the Apples Cancellation Test (from the BCoS), using French-translated administration instructions. The number of the box in which the first crossed-out apple is located, the total performance, the spatial asymmetry score (egocentric neglect), the object asymmetry score (allocentric neglect) and the passing time, in seconds.
12 months
Secondary Outcomes (3)
To establish average scores for healthy French-speaking volunteers without central neurological disorders on the simplified Comb and Razor Test, using French-language administration instructions
inclusion
To establish average scores for healthy French-speaking volunteers without central neurological disorders on the Peg Test, according to their age, sex, and level of occupational qualification.
inclusion
To establish average scores for healthy French-speaking volunteers without central neurological disorders on the 30 cm blind line bisection test using an architect's ruler, according to their age, sex, and level of occupational qualification.
inclusion
Study Arms (1)
group
EXPERIMENTALInterventions
Standardized administration of four paper-and-pencil tests designed to assess different forms of spatial neglect: * Apples Cancellation Test (Birmingham Cognitive Screen) for egocentric and allocentric neglect, * Simplified Comb and Razor Test for personal and motor neglect, * Line Bisection Test (30 cm ruler, blind version) for tactile neglect, * Dot Test for visual exploration. The purpose is to establish normative reference scores in healthy French-speaking adults according to age, sex, and professional qualification. No therapeutic intervention or patient population is involved.
Eligibility Criteria
You may qualify if:
- Healthy volunteer attending the neurovascular department of Raymond-Poincaré Hospital
- Aged between 20 and 89 years
- Affiliated with a health insurance scheme
- French-speaking
- Has freely and knowingly expressed their non-opposition
You may not qualify if:
- Known history of central neurological disease: stroke (ischemic or hemorrhagic), transient ischemic attack, encephalitis, multiple sclerosis, or epilepsy.
- Medical interview suggesting past central nervous system involvement: history of episodes such as sensorimotor deficits, dysarthria, aphasia, blurred or double vision, or positive symptoms such as visual or sensory hallucinations (e.g., paresthesias).
- Significant visual impairment - as judged by the examiner - in near vision despite correction, or monocular blindness. Specifically, inability to distinguish the targets with gaps in the example (pre-test) of the Apples Cancellation Test.
- Abnormal neurological examination:
- National Institutes of Health Stroke Scale (NIHSS) score \> 0
- Pyramidal reflex syndrome (hyperactive deep tendon reflexes with extended reflexogenic zones and spread).
- Use of substances (alcohol or drugs) within 24 hours prior to the assessment.
- Participant under legal protection (guardianship, curatorship, or legal safeguard).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Raymond Poincarré
Garche, 92380, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Jean-Baptiste BRUNET de COURSSOU, Dr
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2025
First Posted
August 28, 2025
Study Start
January 7, 2026
Primary Completion (Estimated)
January 7, 2027
Study Completion (Estimated)
January 7, 2027
Last Updated
February 10, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share